WeVote
Log In

Bill

Bill

PR 26-0689

Board of Pharmacy Dr. Jewell Reddick Confirmation Resolution of 2026

26th Council Period (2025-2026) Introduced by Phil Mendelson

Confirms Dr. Jewell Reddick, a licensed pharmacist with legal/judicial background, to the DC Board of Pharmacy for a term ending March 12, 2028.

Resolution R26-0428, Effective from Jun 30, 2026 Published in DC Register Vol 73 and Page 009431
0
WeVote Research Nonpartisan
Bill Summary · PR 26-0689

Summary of Bill: PR 26-0689 — Board of Pharmacy Dr. Jewell Reddick Confirmation Resolution of 2026

  • Purpose and intent

    • This resolution confirms the appointment of Hon. Dr. Jewell Reddick, PharmD, JD, to the District of Columbia Board of Pharmacy as a pharmacist licensed in the District member. The appointment fills a vacant seat previously held by Ashley Parker Bow and runs for the remainder of an unexpired term ending March 12, 2028.

  • Key provisions and changes

    • Confirmation of appointment: The Council is asked to confirm Dr. Jewell Reddick as a pharmacist licensed in the District member of the Board of Pharmacy, pursuant to the District’s Confirmation Act and Health Occupations Revision Act.
    • Term details: The term expires on March 12, 2028.
    • Transmission of resolution: Upon adoption, a copy of the resolution will be sent to the nominee and to the Mayor’s Office.
    • Immediate effect: The resolution takes effect immediately upon adoption.

  • Nominee background and qualifications

    • Education:
    • Doctor of Pharmacy ( magna cum laude ) from Florida A&M University, College of Pharmacy and Pharmaceutical Sciences (2007)
    • Juris Doctor, cum laude, from the University of Miami (2014)
    • Licensure:
    • Registered Pharmacist in the District of Columbia (and Florida)
    • Maryland Bar: Member in Good Standing
    • Professional experience:
    • Pharmacist roles across CVS Health, Walmart, Kaiser Permanente Capitol Hill, and other notable pharmacy settings, including immunization administration and patient counseling
    • Leadership and supervisory experience in pharmacy operations and budgets
    • Legal/academic experience:
    • Administrative Law Judge, Departmental Appeals Board (DHB) in the U.S. Department of Health and Human Services (since 2023)
    • Former Director/Acting Director/Team Lead within the Civil Remedies Division (Tobacco Cases) of the DAB
    • Experience as Attorney Advisor and Technical Attorney in the same division
    • Board and public service roles:
    • Vice Chair of the District of Columbia Opioid Fatality Review Board (OFRB) since 2020
    • Involved in pharmacy education/community leadership (e.g., Florida A&M University activities)

  • Who is affected

    • State-wide impact on the Board of Pharmacy: Adds a licensed pharmacist with a combined clinical and legal background to the Board, potentially influencing regulatory decisions, disciplinary matters, and professional standards enforcement in the District.
    • Public and healthcare community: Beneficiaries include District residents and patients served by pharmacists and regulatory decisions affecting pharmacy practice and public health policy.

  • Procedural and timeline aspects

    • Nomination and introduction: The Mayor submitted the nomination on May 4, 2026.
    • Referral: The bill was referred to the Committee on Health (Action History shows 2026-05-19 clearance to Health Committee).
    • Legislative effect: Upon adoption, the resolution becomes binding to confirm Dr. Reddick’s appointment; the Mayor and nominee receive copies of the resolution.
    • Effective date: Immediate effect upon adoption, per Sec. 4.

  • Additional context

    • The bill aligns with existing statutory authority: confirmation under the Confirmation Act of 1978 and appointment under the DC Health Occupations Revision Act of 1985.
    • The nomination includes a request for timely Council consideration.

This bill is a straightforward confirmation of a qualified candidate to a regulatory board, balancing clinical pharmacy expertise with legal/regulatory experience to oversee pharmacy practice in the District.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.